Cargando…
Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy
Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004527/ https://www.ncbi.nlm.nih.gov/pubmed/36902810 http://dx.doi.org/10.3390/jcm12052023 |
_version_ | 1784904855368761344 |
---|---|
author | Tanaka, Keiko Sugiyama, Hitoshi Morinaga, Hiroshi Kitagawa, Masashi Kano, Yuzuki Onishi, Yasuhiro Mise, Koki Tanabe, Katsuyuki Uchida, Haruhito A. Wada, Jun |
author_facet | Tanaka, Keiko Sugiyama, Hitoshi Morinaga, Hiroshi Kitagawa, Masashi Kano, Yuzuki Onishi, Yasuhiro Mise, Koki Tanabe, Katsuyuki Uchida, Haruhito A. Wada, Jun |
author_sort | Tanaka, Keiko |
collection | PubMed |
description | Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant cytokines, which were associated with clinical parameters and histological scores in IgAN patients. Results: Among 15 cytokines, the levels of soluble CD40L (sCD40L) and IL-31 were higher in IgAN patients and were significantly associated with a higher estimated glomerular filtration rate (eGFR), a lower urinary protein to creatinine ratio (UPCR), and milder tubulointerstitial lesions (i.e., the early phase of IgAN). Multivariate analysis revealed that serum sCD40L was an independent determinant of a lower UPCR after adjustment for age, eGFR, and mean blood pressure (MBP). CD40, a receptor of sCD40L, has been reported to be upregulated on mesangial cells in IgAN. The sCD40L/CD40 interaction may directly induce inflammation in mesangial areas and may therefore be involved in the development of IgAN. Conclusions: The present study demonstrated the significance of serum sCD40L and IL-31 in the early phase of IgAN. Serum sCD40L may be a marker of the beginning of inflammation in IgAN. |
format | Online Article Text |
id | pubmed-10004527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100045272023-03-11 Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy Tanaka, Keiko Sugiyama, Hitoshi Morinaga, Hiroshi Kitagawa, Masashi Kano, Yuzuki Onishi, Yasuhiro Mise, Koki Tanabe, Katsuyuki Uchida, Haruhito A. Wada, Jun J Clin Med Article Background: IgA nephropathy (IgAN) is a major cause of chronic glomerulonephritis worldwide. T cell dysregulation has been reported to contribute to the pathogenesis of IgAN. Methods We measured a broad range of Th1, Th2 and Th17 cytokines in the serum of IgAN patients. We searched for significant cytokines, which were associated with clinical parameters and histological scores in IgAN patients. Results: Among 15 cytokines, the levels of soluble CD40L (sCD40L) and IL-31 were higher in IgAN patients and were significantly associated with a higher estimated glomerular filtration rate (eGFR), a lower urinary protein to creatinine ratio (UPCR), and milder tubulointerstitial lesions (i.e., the early phase of IgAN). Multivariate analysis revealed that serum sCD40L was an independent determinant of a lower UPCR after adjustment for age, eGFR, and mean blood pressure (MBP). CD40, a receptor of sCD40L, has been reported to be upregulated on mesangial cells in IgAN. The sCD40L/CD40 interaction may directly induce inflammation in mesangial areas and may therefore be involved in the development of IgAN. Conclusions: The present study demonstrated the significance of serum sCD40L and IL-31 in the early phase of IgAN. Serum sCD40L may be a marker of the beginning of inflammation in IgAN. MDPI 2023-03-03 /pmc/articles/PMC10004527/ /pubmed/36902810 http://dx.doi.org/10.3390/jcm12052023 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tanaka, Keiko Sugiyama, Hitoshi Morinaga, Hiroshi Kitagawa, Masashi Kano, Yuzuki Onishi, Yasuhiro Mise, Koki Tanabe, Katsuyuki Uchida, Haruhito A. Wada, Jun Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy |
title | Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy |
title_full | Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy |
title_fullStr | Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy |
title_full_unstemmed | Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy |
title_short | Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy |
title_sort | serum scd40l and il-31 in association with early phase of iga nephropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004527/ https://www.ncbi.nlm.nih.gov/pubmed/36902810 http://dx.doi.org/10.3390/jcm12052023 |
work_keys_str_mv | AT tanakakeiko serumscd40landil31inassociationwithearlyphaseofiganephropathy AT sugiyamahitoshi serumscd40landil31inassociationwithearlyphaseofiganephropathy AT morinagahiroshi serumscd40landil31inassociationwithearlyphaseofiganephropathy AT kitagawamasashi serumscd40landil31inassociationwithearlyphaseofiganephropathy AT kanoyuzuki serumscd40landil31inassociationwithearlyphaseofiganephropathy AT onishiyasuhiro serumscd40landil31inassociationwithearlyphaseofiganephropathy AT misekoki serumscd40landil31inassociationwithearlyphaseofiganephropathy AT tanabekatsuyuki serumscd40landil31inassociationwithearlyphaseofiganephropathy AT uchidaharuhitoa serumscd40landil31inassociationwithearlyphaseofiganephropathy AT wadajun serumscd40landil31inassociationwithearlyphaseofiganephropathy |